Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Oxis in COPD
NCT01069289Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2010
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jan 2010; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01069289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069289.